Together we can sharpen our thinking.
On the path to unicorn status, Huma allows doctors to monitor patients remotely through a mobile app that integrates their data into a dashboard for clinicians to monitor. Since its founding in 2011, it has grown to support a network of more than 27 million patients, and more than 3,000 hospitals and clinics.
London, England-based Huma Therapeutics and Bayer have teamed up to develp an online tool where people can check their risk of getting heart disease. The tool does not replace a physician's assessment, the companies caution, but the 15-question assessment may determine if an individual is at a higher, average, or lower risk for developing heart disease.
Following the acquisition, leading global digital health company Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline.
Health tech company Huma Therapeutics is to form an advanced clinical trials division following the acquisition of Alcedis GmbH.